Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells $159,313.80 in Stock

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CEO Amit Gupta sold 46,857 shares of Cardlytics stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total value of $159,313.80. Following the transaction, the chief executive officer now directly owns 418,637 shares of the company's stock, valued at approximately $1,423,365.80. This represents a 10.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Amit Gupta also recently made the following trade(s):

• On Friday, January 24th, Amit Gupta sold 15,160 shares of Cardlytics stock. The shares were sold at an average price of $3.92, for a total value of $59,427.20.
• On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total transaction of $21,887.88.

Cardlytics Trading Down 9.3 %

CDLX traded down $0.28 during trading on Friday, hitting $2.69. The company's stock had a trading volume of 1,977,881 shares, compared to its average volume of 917,334. Cardlytics, Inc. has a twelve month low of $2.67 and a twelve month high of $20.52. The stock has a market cap of $136.45 million, a PE ratio of -0.44 and a beta of 1.54. The firm's 50 day moving average price is $3.44 and its 200-day moving average price is $3.72. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18.

Analyst Ratings Changes

A number of equities analysts have issued reports on CDLX shares. Needham & Company LLC restated a "hold" rating on shares of Cardlytics in a research report on Friday, January 17th. Craig Hallum raised Cardlytics from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $6.92.

Hedge Funds Weigh In On Cardlytics

Several institutional investors have recently added to or reduced their stakes in the business. Mirabella Financial Services LLP purchased a new stake in Cardlytics in the 4th quarter valued at about $4,285,000. D. E. Shaw & Co. Inc. grew its holdings in Cardlytics by 97.4% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company's stock valued at $4,198,000 after purchasing an additional 558,235 shares during the period. Geode Capital Management LLC grew its holdings in Cardlytics by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,060,739 shares of the company's stock valued at $3,936,000 after purchasing an additional 7,561 shares during the period. RBF Capital LLC increased its position in Cardlytics by 64.7% during the fourth quarter. RBF Capital LLC now owns 803,763 shares of the company's stock worth $2,982,000 after purchasing an additional 315,635 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in Cardlytics by 3.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 402,552 shares of the company's stock worth $1,493,000 after purchasing an additional 12,209 shares during the period. 68.10% of the stock is currently owned by institutional investors and hedge funds.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.